
Episode #37
Market Beat | Episode #37
In episode 37 of Market Beat by Argus Research, host Caroline Wygal covers a rally driven by the U.S. Treasury's announcement that it will increase buybacks of long-dated government debt, pulling interest rates lower and sending the 10-year yield down 5 basis points to 4.66%. In Active Stocks, Moderna skyrockets 94% and Merck gains 8% on positive Phase 3 results from a skin cancer vaccine trial, Target rises 3% on an earnings beat and raised guidance, and Lowe's edges higher despite a cautious outlook on sluggish DIY spending. The Market Buzz breaks down a remarkable earnings season, with S&P 500 second-quarter earnings up over 50% year over year, or closer to 30% excluding one-time gains from Alphabet and Amazon, the second-best growth since 2021. Over 85% of companies beat consensus, with strength extending well beyond AI into Materials, Energy, Industrial, Financial, and Utilities. On valuation, Argus sees stocks as reasonably valued but not bargains, with the Stock/Bond Barometer slightly favoring bonds. Analyst Stephen Biggar delivers Quick Takes with an upgrade of APA Corp to Buy on higher commodity prices and cost reductions, a raised target on Brinker International as its turnaround gains traction, and a raised target on Nucor on steel volume gains. The Deeper Dive examines the shifting Treasury yield curve, which has pushed higher and flattened from a 60 basis point spread in February to 35 today, and what that signals for growth, inflation, and the path to Fed rate cuts in 2027. For full research and information about Argus subscriptions, visit argusresearch.com.

